KR101934775B1 - 캘러스배양을 통한 모링가 유식물체의 대량 증식방법 - Google Patents
캘러스배양을 통한 모링가 유식물체의 대량 증식방법 Download PDFInfo
- Publication number
- KR101934775B1 KR101934775B1 KR1020160114288A KR20160114288A KR101934775B1 KR 101934775 B1 KR101934775 B1 KR 101934775B1 KR 1020160114288 A KR1020160114288 A KR 1020160114288A KR 20160114288 A KR20160114288 A KR 20160114288A KR 101934775 B1 KR101934775 B1 KR 101934775B1
- Authority
- KR
- South Korea
- Prior art keywords
- plant
- medium
- sucrose
- moringa
- seedling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000011347 Moringa oleifera Nutrition 0.000 title claims abstract description 42
- 206010020649 Hyperkeratosis Diseases 0.000 title claims abstract description 40
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000000338 in vitro Methods 0.000 title claims description 5
- 244000179886 Moringa oleifera Species 0.000 title description 2
- 241000196324 Embryophyta Species 0.000 claims abstract description 69
- 241000220215 Moringa Species 0.000 claims abstract description 45
- 239000002609 medium Substances 0.000 claims abstract description 36
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 30
- 229930006000 Sucrose Natural products 0.000 claims abstract description 22
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 22
- 239000005720 sucrose Substances 0.000 claims abstract description 22
- 230000001939 inductive effect Effects 0.000 claims abstract description 19
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 16
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 16
- 229960002920 sorbitol Drugs 0.000 claims abstract description 16
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 14
- 229960000367 inositol Drugs 0.000 claims abstract description 14
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 14
- 230000008929 regeneration Effects 0.000 claims abstract description 11
- 238000011069 regeneration method Methods 0.000 claims abstract description 11
- 229920001817 Agar Polymers 0.000 claims abstract description 6
- 239000008272 agar Substances 0.000 claims abstract description 6
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 5
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 18
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims description 14
- 239000005971 1-naphthylacetic acid Substances 0.000 claims description 12
- IIDAJRNSZSFFCB-UHFFFAOYSA-N 4-amino-5-methoxy-2-methylbenzenesulfonamide Chemical compound COC1=CC(S(N)(=O)=O)=C(C)C=C1N IIDAJRNSZSFFCB-UHFFFAOYSA-N 0.000 claims description 12
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 11
- 229960003512 nicotinic acid Drugs 0.000 claims description 9
- 235000001968 nicotinic acid Nutrition 0.000 claims description 9
- 239000011664 nicotinic acid Substances 0.000 claims description 9
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims description 9
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 9
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 9
- 229960003495 thiamine Drugs 0.000 claims description 9
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 9
- 229940011671 vitamin b6 Drugs 0.000 claims description 9
- 229910016374 CuSO45H2O Inorganic materials 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 8
- 230000001172 regenerating effect Effects 0.000 claims description 8
- 239000007836 KH2PO4 Substances 0.000 claims description 7
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 7
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 7
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 7
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 claims description 7
- 235000010333 potassium nitrate Nutrition 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 239000004471 Glycine Substances 0.000 claims description 6
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims description 6
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims description 6
- 229960001669 kinetin Drugs 0.000 claims description 6
- 239000000126 substance Substances 0.000 claims description 6
- 229920002148 Gellan gum Polymers 0.000 claims description 5
- 239000007640 basal medium Substances 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 201000001421 hyperglycemia Diseases 0.000 claims description 2
- 239000011541 reaction mixture Substances 0.000 claims description 2
- 230000006698 induction Effects 0.000 abstract description 7
- 230000001965 increasing effect Effects 0.000 abstract description 6
- 239000001963 growth medium Substances 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000008676 import Effects 0.000 abstract description 3
- 238000006467 substitution reaction Methods 0.000 abstract description 2
- 230000001766 physiological effect Effects 0.000 abstract 1
- 230000003252 repetitive effect Effects 0.000 abstract 1
- 238000012258 culturing Methods 0.000 description 8
- 230000004069 differentiation Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 239000011573 trace mineral Substances 0.000 description 6
- 235000013619 trace mineral Nutrition 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 241000218922 Magnoliophyta Species 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 230000000408 embryogenic effect Effects 0.000 description 4
- 239000003630 growth substance Substances 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 239000013028 medium composition Substances 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000032823 cell division Effects 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 240000002778 Neonotonia wightii Species 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000306 component Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 230000035784 germination Effects 0.000 description 2
- 238000003306 harvesting Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000029553 photosynthesis Effects 0.000 description 2
- 238000010672 photosynthesis Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000003104 tissue culture media Substances 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 229930192334 Auxin Natural products 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000446313 Lamella Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000220214 Moringaceae Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000019552 anatomical structure morphogenesis Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002363 auxin Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000010413 gardening Methods 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 229960003284 iron Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000002015 leaf growth Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 239000012913 medium supplement Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 230000037125 natural defense Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000003415 peat Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000002786 root growth Effects 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/005—Methods for micropropagation; Vegetative plant propagation using cell or tissue culture techniques
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/001—Culture apparatus for tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/002—Culture media for tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/008—Methods for regeneration to complete plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0025—Culture media for plant cell or plant tissue culture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/04—Plant cells or tissues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Botany (AREA)
- Health & Medical Sciences (AREA)
- Environmental Sciences (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
상기 유식물체를 성장시키는 단계는, 상기 상기 유식물체의 형성 및 식물체를 재분화하는 단계에서 배양된 유식물체를, 수크로우스(Sucrose) 30g~40g/L, 소르비톨(D-sorbitol) 30g/L, 이노시톨(inositol) 0.1g/L 및 아가(Agar) 8~10g/L을 기본 배지에 더 첨가한 배지에서 성장시키는 것을 특징으로 하는 모링가의 기내 유식물체 형성방법으로 배양 규모를 확대하는 증식 배양 과정에서 낙엽이지지 않고 생리활성을 높여 유식물체 수를 증가하기 유리하며, 전체 유식물체 형성 기간은 3~4개월로 단축할 수 있어 농가들에게 모링가 모종을 대량으로 공급할 수 있고, 재배기간이 5월에서 10월까지로 짧은 국내 기후환경에서도 농가에서 잎과 줄기 및 뿌리를 수확할 수 있으므로 농가 소득증대 및 모링가의 수입대체 효과를 얻을 수 있다.
Description
도 2는 모링가의 캘러스(callus) 배양에 이용할 종자 치상 및 부정아 형성을 보여주는 사진이다.
도 3은 본 발명에 따른 모링가의 캘러스(callus) 배양을 이용한 식물체 형성 과정들을 단계별로 나타낸 사진이다.
구 분 | 성분명 | 함량(mg/L) | ||
무기염류 (다량원소) |
KNO3 | 1,900 | ||
NH4NO3 | 1,650 | |||
CaCl22H2O | 440 | |||
MgSO47H2O | 370 | |||
KH2PO4 | 170 | |||
무기염류 (미량원소) |
MnSO44H2O | 22.3 | ||
ZnSO47H2O | 8.6 | |||
H3BO3 | 6.2 | |||
KI | 0.83 | |||
CuSO45H2O | 0.025 | |||
Na2MoO42H2O | 0.25 | |||
CoCL26H2O | 0.025 | |||
FeSO47H2O | 27.8 | |||
Na2EDTA2H2O | 37.3 | |||
유기물질 | glycine | 2 | ||
myo-inositol | 100 | |||
nicotinic acid | 0.5 | |||
pyridoxineHCl | 0.5 | |||
thiamineHCl | 0.1 | |||
sucrose | 3% | |||
casamino acid | 100 |
캘러스형성율(%) | 신초분화율(%) | 신초개수/(plantlet) |
52.7±5.2 | 15.7±1.5 | 11.2±1.1 |
구 분 | 성분명 | 함량(mg/L) |
무기염류 (다량원소) |
KNO3 | 1,900 |
NH4NO3 | 1,650 | |
CaCl22H2O | 440 | |
MgSO47H2O | 370 | |
KH2PO4 | 170 | |
무기염류 (미량원소) |
MnSO44H2O | 22.3 |
ZnSO47H2O | 8.6 | |
H3BO3 | 6.2 | |
KI | 0.83 | |
CuSO45H2O | 0.025 | |
Na2MoO42H2O | 0.25 | |
CoCL26H2O | 0.025 | |
FeSO47H2O | 27.8 | |
Na2EDTA2H2O | 37.3 | |
유기물질 | glycine | 2 |
myo-inositol | 100 | |
nicotinic acid | 0.5 | |
pyridoxineHCl | 0.5 | |
thiamineHCl | 0.1 | |
sucrose | 3% | |
sorbitol | 2% |
구 분 | 신초분화율(%) | 신초개수(plantlet) | 신초장(mm) |
12주차 | 31.7±3.1 | 27.5±2.7 | 25.2±2.5 |
20주차 | 52.7±5.2 | 45.7±4.5 | 42.8±4.2 |
구 분 | 성분명 | 함량(mg/L) |
무기염류 (다량원소) |
KNO3 | 2,850 |
NH4NO3 | 2,470 | |
CaCl22H2O | 660 | |
MgSO47H2O | 550 | |
KH2PO4 | 255 | |
무기염류 (미량원소) |
MnSO44H2O | 33.1 |
ZnSO47H2O | 12.3 | |
H3BO3 | 9.1 | |
KI | 1.2 | |
CuSO45H2O | 0.037 | |
Na2MoO42H2O | 0.37 | |
CoCL26H2O | 0.037 | |
FeSO47H2O | 41.7 | |
Na2EDTA2H2O | 55.9 | |
유기물질 | glycine | 3 |
myo-inositol | 250 | |
nicotinic acid | 0.75 | |
pyridoxineHCl | 0.75 | |
thiamineHCl | 0.15 | |
sucrose | 3% | |
sorbitol | 3% |
식물체 형성율(%) | 신초개수(plantlet) | 엽수(leaf) | 초장(mm) |
52.5±5.2 | 3.7±3 | 75.4±7.5 | 94±9.4 |
Claims (6)
- 배지에서 캘러스(callus) 형성 및 다신초 유도를 하고, 형성된 유식물체를 재분화하는 단계, 재분화된 유식물체를 성장시키는 단계를 포함하는 모링가의 기내유식물체 형성 방법에 있어서,
상기 캘러스 형성 및 다신초를 유도하는 단계는 기내 배양중인 유식물체의 줄기, 뿌리 및 잎에서 채취한 작은 식물조직을 카사미노산(casamino acid) 0.1g/L, 2.4-D(2.4-dichloro phenoxy acetic acid) 20mg/L, 수크로우스(Sucrose) 30g/L 및파이타겔(phytagel) 2~3g/L을 기본 배지에 더 첨가한 배지에 치상하여 배양하고,
상기 유식물체의 형성 및 식물체를 재분화하는 단계는, 상기 캘러스 형성 및 다신초를 유도하는 단계에서 배양된 유식물체를 분화하여, 키네틴(Kinetin) 20mg/L, 1-나프탈렌아세트산(1-naphthaleneacetic acid; NAA) 2mg/L, 수크로우스(Sucrose) 30g~40g/L, 소르비톨(D-sorbitol) 20g/L 및 파이타겔(Pytagel) 2~3g/L을 기본 배지에 더 첨가한 배지에서 배양하며,
상기 유식물체를 성장시키는 단계는, 상기 유식물체의 형성 및 식물체를 재분화하는 단계에서 배양된 유식물체를, 수크로우스(Sucrose) 30g~40g/L, 소르비톨(D-sorbitol) 30g/L, 이노시톨(inositol) 0.1g/L 및 아가(Agar) 8~10g/L을 기본 배지에 더 첨가한 배지에서 성장시키는 것을 특징으로 하는 모링가의 기내 유식물체형성방법.
- 삭제
- 삭제
- 제 1항에 있어서,
상기 캘러스 형성 및 다신초를 유도하는 단계에서의 배지는 KNO3 1,900mg/L, NH4NO3 1,650mg/L, CaCl22H2O 440mg/L, MgSO47H2O 370mg/L, KH2PO4 170mg/L, MnSO44H2O 22.3mg/L, ZnSO47H2O 8.6mg/L, H3BO3 6.2mg/L, KI 0.83mg/L, CuSO45H2O 0.025mg/L, Na2MoO42H2O 0.25mg/L, CoCL26H2O 0.025mg/L, FeSO47H2O 27.8mg/L, Na2EDTA2H2O 37.3mg/L의 무기 염류와, glycine 2mg/L, myo-inositol 100mg/L, nicotinic acid 0.5mg/L, pyridoxineHCl 0.5mg/L, thiamineHCl 0.1mg/L, sucrose 3%, casamino acid 100mg/L의 유기물을 포함하여 조성되는 것을 특징으로 하는 모링가의 기내 유식물체 형성방법.
- 제 1항에 있어서,
상기 유식물체의 형성 및 식물체를 재분화하는 단계에서의 배지는, KNO3 1,900mg/L, NH4NO3 1,650mg/L, CaCl22H2O 440mg/L, MgSO47H2O 370mg/L, KH2PO4 170mg/L, MnSO44H2O 22.3mg/L, ZnSO47H2O 8.6mg/L, H3BO3 6.2mg/L, KI 0.83mg/L, CuSO45H2O 0.025mg/L, Na2MoO42H2O 0.25mg/L, CoCL26H2O 0.025mg/L, FeSO47H2O 27.8mg/L, Na2EDTA2H2O 37.3mg/L의 무기 염류와, glycine 2mg/L, myo-inositol 100mg/L, nicotinic acid 0.5mg/L, pyridoxineHCl 0.5mg/L, thiamineHCl 0.1mg/L, sucrose 3%, sorbitol 2%의 유기물을 포함하여 조성되는 것을 특징으로 하는 모링가의 기내 유식물체 형성방법.
- 제 1항에 있어서,
상기 유식물체를 성장시키는 단계에서의 배지는, KNO3 2,850mg/L, NH4NO3 2,470mg/L, CaCl22H2O 660mg/L, MgSO47H2O 550mg/L, KH2PO4 255mg/L, MnSO44H2O 33.1mg/L, ZnSO47H2O 12.3mg/L, H3BO3 9.1mg/L, KI 1.2mg/L, CuSO45H2O 0.037mg/L, Na2MoO42H2O 0.37mg/L, CoCL26H2O 0.037mg/L, FeSO47H2O 41.7mg/L, Na2EDTA2H2O 55.9mg/L의 무기 염류와, glycine 3mg/L, myo-inositol 250mg/L, nicotinic acid 0.75mg/L, pyridoxineHCl 0.75mg/L, thiamineHCl 0.15mg/L, sucrose 3%, sorbitol 3%의 유기물을 포함하여 조성되는 것을 특징으로 하는 모링가의 기내 유식물체 형성방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160114288A KR101934775B1 (ko) | 2016-09-06 | 2016-09-06 | 캘러스배양을 통한 모링가 유식물체의 대량 증식방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160114288A KR101934775B1 (ko) | 2016-09-06 | 2016-09-06 | 캘러스배양을 통한 모링가 유식물체의 대량 증식방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180027116A KR20180027116A (ko) | 2018-03-14 |
KR101934775B1 true KR101934775B1 (ko) | 2019-01-03 |
Family
ID=61660314
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160114288A Active KR101934775B1 (ko) | 2016-09-06 | 2016-09-06 | 캘러스배양을 통한 모링가 유식물체의 대량 증식방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101934775B1 (ko) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102315138B1 (ko) * | 2021-07-16 | 2021-10-20 | 주식회사 코스니즈 | 항노화 식물유래줄기세포 캘러스 복합 추출물을 함유하는 탈모방지 및 모발성장 촉진용 샴푸 조성물 및 그 제조방법 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100889342B1 (ko) * | 2007-10-15 | 2009-03-20 | 대한민국 | 체세포배 발생을 이용한 백합나무의 번식방법 |
-
2016
- 2016-09-06 KR KR1020160114288A patent/KR101934775B1/ko active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100889342B1 (ko) * | 2007-10-15 | 2009-03-20 | 대한민국 | 체세포배 발생을 이용한 백합나무의 번식방법 |
Also Published As
Publication number | Publication date |
---|---|
KR20180027116A (ko) | 2018-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104273028B (zh) | 一种景天科植物快速离体繁殖的方法 | |
Lesar et al. | Acclimatization of terrestrial orchid Bletilla striata Rchb. f.(Orchidaceae) propagated under in vitro conditions | |
CN109258460A (zh) | 微茎尖培养结合热处理获得增城蜜菊脱毒苗的培育方法 | |
CN104273027B (zh) | 一种景天科植物种子的无菌萌发方法 | |
KR101290257B1 (ko) | 생장점 배양 방법을 이용한 블루베리 품종인 블루골드, 엘리자베스, 다로우, 오따드 또는 티프블루의 식물체 형성 방법 | |
CN100334946C (zh) | 一种迎红杜鹃组培快繁和移栽方法 | |
KR20110113918A (ko) | 정단배양 방법을 이용한 블루베리의 식물체 형성 방법 | |
CN101548646B (zh) | 一种通过体细胞胚及次生体细胞胚发生途径快繁龙牙楤木的方法 | |
CN103688863B (zh) | 一种利用胚芽体细胞培育性状改良的野生构树的方法 | |
CN114711140B (zh) | 一种欧洲越橘愈伤组织再生体系的建立方法 | |
KR101934786B1 (ko) | 연중 계속적인 생산을 위한 모링가 재배방법 | |
KR101934775B1 (ko) | 캘러스배양을 통한 모링가 유식물체의 대량 증식방법 | |
CN1224314C (zh) | 日本落叶松微体繁殖的根诱导方法 | |
CN106665364B (zh) | 龙牙百合杂交后代鳞茎膨大发育及生根的方法 | |
KR101934780B1 (ko) | 모링가의 줄기마디 배양을 통한 기내 유식물체 형성방법 | |
CN112616675B (zh) | 一种舞花姜组织培养快速繁殖方法 | |
KR101405391B1 (ko) | 블루베리 품종인 웨어마우스,듀크,블루레이,넬슨,노스랜드 또는 스파르탄의 생장점 배양 방법을 이용한 식물체 형성 방법 | |
KR101933768B1 (ko) | 모링가의 뿌리배양을 통한 기내 유식물체 형성방법 | |
KR101934778B1 (ko) | 모링가의 겨드랑이 눈부위 생장점 배양을 통한 기내 유식물체 형성방법 | |
CN106605596A (zh) | 一种通过体胚发生大量繁殖忽地笑的方法 | |
CN107889745B (zh) | 一种避免杉木试管苗偏冠的组培方法 | |
GB2099851A (en) | Propagating foxglove from sterile seeds or shoot apices | |
Kumar et al. | Tissue Culture Approaches to Strawberries Improvement | |
KR101934781B1 (ko) | 모링가의 기내 유식물체 형성을 위한 성장배지 | |
CN111528098A (zh) | 一种当归组培苗生根培养方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20160906 |
|
PA0201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20180111 Patent event code: PE09021S01D |
|
PG1501 | Laying open of application | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20180918 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20181227 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20181227 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20210917 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20220920 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20231024 Start annual number: 6 End annual number: 6 |